3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
46
Leukemia, Lymphocytic, Chronic, B-Cell
18
Myelodysplastic Syndromes
8
Burkitt Lymphoma
7
Waldenstrom Macroglobulinemia
6
Lymphoma, B-Cell, Marginal Zone
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Biphenotypic, Acute
4
Recurrence
3
Neoplasms
3
Myeloproliferative Disorders
3
Lymphoma
3
Leukemia, Myelomonocytic, Chronic
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Hematologic Neoplasms
2
Blast Crisis
2
Anemia, Refractory, with Excess of Blasts
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Hairy Cell
1
Interventions
Bevacizumab
13
atezolizumab
9
Specimen Handling
9
durvalumab
8
Nivolumab
7
Magnetic Resonance Spectroscopy
7
tremelimumab
6
lenvatinib
6
cabozantinib
4
Sorafenib
4
tislelizumab
3
donafenib
3
X-Rays
3
Surgical Procedures, Operative
3
Oxaliplatin
3
Ipilimumab
3
Immunotherapy
3
Fluorouracil
3
ulixertinib
2
sintilimab
2
sapanisertib
2
relatlimab
2
pembrolizumab
2
camrelizumab
2
apatinib
2
Leucovorin
2
Irinotecan
2
Fluorodeoxyglucose F18
2
Doxorubicin
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
venetoclax
×
30 days
×
Clear all
No trials found.